Changes of bone mineral density and bone metabolism marker in newly diagnosed hyperthyroidism patients

吴佩娴,张帆,蓝薇,戴亚丽,陈说,郇婕,叶敏
DOI: https://doi.org/10.14163/j.cnki.11-5547/r.2015.15.010
2015-01-01
Abstract:Objective To investigate the changes of bone mineral density and bone metabolism marker in newly diagnosed hyperthyroidism patients. Methods There were 32 patients with hyperthyroidism as hyperthyroidism group, and another 30 healthy people as control group. Detection was taken for serum alkaline phosphatase (ALP), calcium (Ca2+), free triiodothyronine (FT3), free thyroxine (FT4), thyroid stimulating hormone (TSH), serum osteocalcin (N-MID),β-collagen special sequence (β-CTx), total procollagen type Ⅰ amino-terminal propeptide (tP1NP), and femoral neck bone mineral density (BMD) for comparative analysis. Results The hyperthyroidism group had much higher serum ALP, Ca2+, FT3, FT4,β-CTx, N-MID, tP1NP and lower TSH than control group, and their differences had statistical signficance (P<0.05);and its femoral neck BMD was lower than the control group (P<0.05). tP1NP,β-CTx, and N-MID were respectively in positive correlation with FT3 and FT4, and in negative correlation with TSH (P<0.05). N-MID and femoral neck BMD had negative correlation (P<0.05). Conclusion Bone metabolism markers of formation and resorption were all increased in newly diagnosed hyperthyroidism patients. They had lost bone mass, and easily had high conversion osteoporosis.
What problem does this paper attempt to address?